News|Podcasts|September 8, 2023

Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS

Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.

Florida Cancer Specialists & Research Institute's (FCS') Nathan Walcker, CEO, discusses some key strategic practices and initiatives in providing high quality community-based oncology care he has implemented at FCS.

He spoke with us at The American Journal of Managed Care®’s Institute for Value-Based Medicine® event held in Tampa, Florida, on August 10, 2023.

Listen above or through one of these podcast services:

iTunes
TuneIn
Stitcher
Spotify

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related to this article

Michael S. Barr, MD< MBA, MACP, FRCP | Image Credit: © MEDIC LLS

October 2nd, 2026

VBC Risk Is Outpacing Provider Readiness, CMS Must Act

CMS is adding value-based care (VBC) risk faster than many providers can build the data and tech capacity they need to succeed.

Close up of Retatrutide Glass Vial and Single Use Insulin Syringes | Image credit: Anna Hoychuk - stock.adobe.com

October 7th, 2026

5 Things to Know if Retatrutide Is Classified as a Biologic

A legal fight over a single amino acid could set retatrutide's exclusivity window, its Medicare negotiation clock, and its competitive future.

Health care cost concept. | Image credit: @inthasone_AdobeStock.jpeg

October 6th, 2026

CMS Moves TIC Reporting to Quarterly, Sets Drug File Timeline

CMS finalized Transparency in Coverage updates as a researcher warns ghost rates and missing inpatient data limit payer price files.

Health care cost | Image credit: digicomphoto - stock.adobe.com

October 5th, 2026

Traditional Medicare OOP Cap Could Lower Costs, Raise Federal Spending

A traditional Medicare out-of-pocket (OOP) cap could reduce beneficiaries’ costs but increase annual federal spending by $39 billion to $96 billion.

October 2nd, 2026

Building a Scalable Obesity Care Team: Amanda Velazquez, MD

Build scalable obesity care with multidisciplinary teams, clear triage, and monitoring protocols; address GLP-1 gaps, Medicare access and price barriers, including oral GLP-1.

Daniel Kyung Min, PharmD | Image: LinkedIn

October 1st, 2026

High-Intensity IV Iron Replacement for Chronic Bleeding in HHT: A Case Series

The article explores the use of dose-intensive IV iron replacement to achieve long-term hemoglobin stability in patients with moderate to severe HHT-related bleeding. The approach recognizes what the author calls "the relentless and recurrent nature of HHT-associated bleeding," and may help patients achieve better quality of life.